NCT06749106

Brief Summary

The aim of this study is to investigate the association between intraplaque hemorrhage (IPH) detected by non-contrast magnetic resonance imaging (MRI) of the carotid artery in routine clinical practice and ipsilateral acute ischemic events. The investigators' overarching aim is to determine whether this sequence aids the diagnostic work-up of stroke patients. For this purpose, the investigators set up a prospective single-center longitudinal observational study with one year follow-up. In addition, this study will analyze retrospectively obtained data collected through clinical routine.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
44mo left

Started Jan 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress26%
Jan 2025Dec 2029

First Submitted

Initial submission to the registry

December 19, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 27, 2024

Completed
20 days until next milestone

Study Start

First participant enrolled

January 16, 2025

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2029

Last Updated

January 24, 2025

Status Verified

January 1, 2025

Enrollment Period

4 years

First QC Date

December 19, 2024

Last Update Submit

January 21, 2025

Conditions

Keywords

plaque imagingplaque vulnerabilitycryptogenic strokeroutine carestroke etiologyrecurrent strokeintraplaque hemorrhageIPHacute ischemic strokeAIS

Outcome Measures

Primary Outcomes (1)

  • intraplaque hemorrhage (IPH)

    presence of IPH as detected on routine non-contrast MRI

    baseline

Secondary Outcomes (5)

  • recurrent ischemic stroke or TIA

    3 months, 12 months

  • Plaque-RADS

    baseline

  • Barthel Scale

    baseline, 3 months, 12 months

  • modified Rankin Scale (mRS)

    baseline, 3 months, 12 months

  • National Institutes of Health Stroke Scale (NIHSS)

    baseline

Study Arms (1)

acute ischemic stroke

Patients with acute ischemic stroke, who received non-contrast carotid MRI for routine diagnostic work-up

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with acute ischemic stroke, who received non-contrast carotid MRI for routine diagnostic work-up, will be asked whether they are willing to participate in a prospective, longitudinal study with telephone follow-up to assess recurrent ischemic stroke or TIA. Patients who are unable to provide informed consent for themselves, children and adolescents will not be recruited. Detailed eligibility criteria for the prospective longitudinal study are provided above. In addition, this study will analyse retrospectively obtained data collected through clinical routine: These analyses will be done on all patients who received non-contrast carotid MRI for routine diagnostic work-up over the last years. This approach allows to estimate the prevalence of IPH in an unselected patient population.

You may qualify if:

  • Patients with acute ischemic stroke
  • Availability of non-contrast carotid MRI scans obtained through routine diagnostic work-up

You may not qualify if:

  • Infarct in the posterior circulation or bilateral ischemic infarcts
  • Time between symptom onset and non-contrast carotid MRI \> 10 days
  • Prior stenting of a carotid artery or carotid endarterectomy
  • Age \< 18 years
  • Life expectancy \< 1 year
  • Inability to provide written informed consent
  • This eligibility criteria apply for the prospective part of the PARADE study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute for Stroke and Dementia Research

Munich, 81377, Germany

RECRUITING

MeSH Terms

Conditions

Ischemic StrokeStroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Anna Kopczak, MD

    Institute for Stroke and Dementia Research

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Martin Dichgans, Prof.

CONTACT

Anna Kopczak, MD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. med. Martin Dichgans

Study Record Dates

First Submitted

December 19, 2024

First Posted

December 27, 2024

Study Start

January 16, 2025

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2029

Last Updated

January 24, 2025

Record last verified: 2025-01

Locations